Study of sulopenem in teens with bacterial infections
This trial tests an oral antibiotic called sulopenem for teenagers (12 to under 18) who have a bacterial infection. It checks how the drug works in the body and may offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to under 18 years old.
- You have a bacterial infection diagnosed by a doctor.
- You can take oral medications and have good veins for blood draws.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You agree to use highly effective birth control if you are postmenarchal (female) or post-pubertal (male) during the study and for one month after the last dose.
- You do not have kidney problems, severe infections (like meningitis), or known allergies to penicillin-like drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of an investigational antibiotic called gepotidacin in children aged 2 to 12 who have a bacterial infection or are taking antibiotics to prevent one. The goal is to see how the medicine works in young patients.
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
This trial tests how a new antibiotic (meropenem-pralubactam) moves into the lungs of healthy people in China. You will receive the medicine through an IV, and a lung fluid sample will be collected to measure the drug levels.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial studies how the antibiotic temocillin works in children with a kidney infection caused by certain bacteria. It may help doctors give the right dose for better treatment.
This trial tests a new antibiotic combination, cefepime/enmetazobactam, against standard therapy for people with complicated urinary tract infections that have spread to the bloodstream. It aims to see if the new drug works better and is safe.
Hear when a new Pharmacokinetics After Oral Intake trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.